Alnylam Pharmaceuticals, Inc.

KBC Group NV ALNY
Report date
12/31/2025
Quarter
2025 Q4
Filed
1/26/2026
Shares
348,194
Value ($000)
138,459
Weight
0.3%
2025 Q2 - 2025 Q4 (3 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).